Menu

Virgin Orbit Ventilators

Stars
Ready to get started? Choose an option:

 

 

Have a question or a complaint? If you are a medical professional seeking Ventilator Device Support, please contact 1-800-576-6695 during business hours (7am – 5pm PDT) or complete the form below.

 

Sales or other inquiries see Ventilator Interest.

 

Please – absolutely no sales calls – our phone line is only for healthcare workers with questions or complaints about their devices.

 

Ventilator Delivery Update

 

 

For companies and organizations interested in:

  • Obtaining a device
  • Manufacturing devices
  • General information about the project

Please fill out the form below.

 

Virgin Orbit Ventilators

With guidance from medical experts at the University of California-Irvine (UCI) and the University of Texas at Austin (UT Austin), Virgin Orbit has developed a new mass-producible bridge ventilator to help in the fight against the coronavirus (COVID-19) pandemic.

Our device has now been authorized for use in the U.S. during the COVID-19 National Emergency. We have begun production, with the first 100 units expected to be delivered before the end of April; and we anticipate delivering hundreds of units per week going forward.

Read the Full Story

Form & Function

The Virgin Orbit ventilator is intended to provide automated, continuous or intermittent ventilatory support for patients suffering from respiratory failure. The beauty of the device is its simplicity, making it easy to deploy in a hospital or in the field, and extremely fast and inexpensive to manufacture.

The ventilator is in essence a very simple, very reliable, mechanical device designed to automate common manual resuscitators (also known as bag valve masks, and often referred to colloquially by the proprietary name “Ambu-bag”). The system can be used to treat moderate hypoxic and/or hypercarbic respiratory failure – in most settings, this would include the majority of COVID-19 patients – freeing up existing, more sophisticated ventilators to be used on patients with the most severe symptoms.